VahatiCor Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$30.4M
- Investors
-
4
VahatiCor General Information
Description
Developer of medical devices designed to treat coronary microvascular dysfunction. The company's technology utilizes a self-expanding nitinol mesh delivered to the coronary sinus to redistribute oxygenated blood and enhance myocardial perfusion, enabling the healthcare industry to provide relief for patients with persistent angina and improve cardiac microcirculatory function.
Contact Information
Website
www.vahaticor.comCorporate Office
- 2903 Bunker Hill Lane
- Suite 100
- Santa Clara, CA 95054
- United States
Corporate Office
- 2903 Bunker Hill Lane
- Suite 100
- Santa Clara, CA 95054
- United States
VahatiCor Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 20-Oct-2026 | $30.4M | Completed | Clinical Trials - General | ||
| 1. Early Stage VC (Series A) | 20-May-2022 | Completed | Pre-Clinical Trials |
VahatiCor Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A-2 | 5,952,491 | $0.000001 | $0.09 | $0.09 | 1x | $0.09 | 2.71% | |
| Series A-1 | 24,222,850 | $0.000001 | $0.25 | $0.25 | 1x | $0.25 | 11.03% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
VahatiCor Comparisons
Industry
Financing
Details
VahatiCor Competitors (1)
One of VahatiCor’s competitors is ShockWave Medical, a Formerly VC-backed company based in Santa Clara, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ShockWave Medical | Formerly VC-backed | Santa Clara, CA |
VahatiCor Patents
VahatiCor Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026516522-A | Self-expanding vascular flow reducer with a stabilized throat. | Pending | 17-May-2023 |
VahatiCor Signals
VahatiCor Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Intuitive Ventures | Corporate Venture Capital | Minority | ||
| S3 Ventures | Venture Capital | Minority | ||
| Kinled Holding | Family Office | Minority | ||
| T45 Labs | Accelerator/Incubator | Minority |
VahatiCor FAQs
-
When was VahatiCor founded?
VahatiCor was founded in 2018.
-
Where is VahatiCor headquartered?
VahatiCor is headquartered in Santa Clara, CA.
-
What is the size of VahatiCor?
VahatiCor has 22 total employees.
-
What industry is VahatiCor in?
VahatiCor’s primary industry is Therapeutic Devices.
-
Is VahatiCor a private or public company?
VahatiCor is a Private company.
-
What is the current valuation of VahatiCor?
The current valuation of VahatiCor is .
-
What is VahatiCor’s current revenue?
The current revenue for VahatiCor is .
-
How much funding has VahatiCor raised over time?
VahatiCor has raised $37.1M.
-
Who are VahatiCor’s investors?
Intuitive Ventures, S3 Ventures, Kinled Holding, and T45 Labs have invested in VahatiCor.
-
Who are VahatiCor’s competitors?
ShockWave Medical is a competitor of VahatiCor.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process